Personal Information
Unternehmen/Arbeitsplatz
Bangladesh Bangladesh
Beruf
B.Pharm,
Superintendent of Drugs @ DGDA
Branche
Government / Military
Webseite
http://www.dgda.gov.bd
Info
Experienced Superintendent with a demonstrated history of working in the National Regulatory Agency for Drugs & Devices named "Directorate General of Drug Administration (DGDA)" under The Ministry of Health & Family Welfare (MOHFW)Skilled in WHO-GMP,PQS,Pharmaceutics, Root cause Analysis (RCA),Corrective and Preventive Action (CAPA), Microsoft Word, and Life Sciences.Gained Advanced QRM knowledge through participation in the QRM CIRCLE Led by PIC/S in PMDA, Japan & FDA Los Angels district office held on 2014-2015 respectively. Striving professional with a keen acumen for settling down into the Global Auditors Guild completed Master of Public Health (MPH) focused in Epidemiology from North...
- Präsentationen
- Dokumente
- Infografiken
5S: A Workplace Organization Method
Nanette Bajador
•
Vor 10 Jahren
Process Validation for Beginners - FDA - EMA Approach
GMP EDUCATION : Not for Profit Organization
•
Vor 11 Jahren
The Network Effects Bible
NFX
•
Vor 6 Jahren
Good Laboratory Practices for Pharmaceutical Quality Control Laboratories
Sathish Vemula
•
Vor 9 Jahren
Checklist
dygmasnah65
•
Vor 9 Jahren
Pharmacokinetics and Pharmacodynamics
Bhaswat Chakraborty
•
Vor 11 Jahren
Global Subbmission of IND, NDA, ANDA
Maruthi.N
•
Vor 6 Jahren
SAP in Pharmaceutical Industry
Chandra Shekar
•
Vor 14 Jahren
AgilePM® V2 - Agile Project Management V2 - Foundation
Mirosław Dąbrowski C-level IT manager, CEO, Agile, ICF Coach, Speaker
•
Vor 9 Jahren
Gmp Auditor Training Course
piyush64173
•
Vor 14 Jahren
ウェブセキュリティの最近の話題早分かり
Hiroshi Tokumaru
•
Vor 6 Jahren
Powder flow testing and control
Nitin Patel
•
Vor 10 Jahren
Prevention of counterfeit medicine
Nitin Patel
•
Vor 10 Jahren
MHRA Data Integrity Requirements
GMP EDUCATION : Not for Profit Organization
•
Vor 9 Jahren
FDA’s approach to regulation of in vitro diagnostic tests
MaRS Discovery District
•
Vor 13 Jahren
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) Body for Pharmaceutical Product Development with QbD
Shivang Chaudhary
•
Vor 10 Jahren
Risk-Based Approaches in GMP’s Project Life Cycles
Institute of Validation Technology
•
Vor 11 Jahren
What is a biosimilar? All you need to know about the current biologics and biosimilars landscape in Canada
Canadian Cancer Survivor Network
•
Vor 8 Jahren
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
vasanthi chodavarapu
•
Vor 7 Jahren
FDA Regulation of Social Media and the Internet
Michael Swit
•
Vor 9 Jahren